{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:50:09Z","timestamp":1790214609246,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jdiacomp.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T09:38:13Z","timestamp":1434101893000},"page":"1261-1265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Adverse event notifications implicating metformin with lactic acidosis in Australia"],"prefix":"10.1016","volume":"29","author":[{"given":"Weiyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Castelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0015","unstructured":"Type 2 Diabetes: The management of type 2 diabetes (NICE clinical guideline 87). National Institute for Health and Care Excellence [updated July 2014]; 2009. Available at: https:\/\/www.nice.org.uk\/guidance\/cg87. (accessed 21 October 2014)."},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0120","series-title":"The pharmaceutical benefits scheme","author":"Australian Statistics on Medicines","year":"1997"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0050","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc08-1171","article-title":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case\u2013control analysis","volume":"31","author":"Bodmer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/diab.32.2.181","article-title":"Lactic acidosis revisited","volume":"32","author":"Cohen","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0215","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.annemergmed.2009.04.023","article-title":"Acute metformin overdose: Examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: A systematic review of the literature","volume":"54","author":"Dell'Aglio","year":"2009","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1464-5491.2001.00509.x","article-title":"Contraindications to metformin therapy in patients with type 2 diabetes\u2013A population-based study of adherence to prescribing guidelines","volume":"18","author":"Emslie-Smith","year":"2001","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0005","series-title":"Melbourne: The Royal Australian College of General Practitioners and Diabetes Australia","author":"General practice management of type 2 diabetes -2014-15","year":"2014"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0095","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s00125-005-0026-1","article-title":"Contraindications can damage your health\u2013Is metformin a case in point?","volume":"48","author":"Holstein","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/imj.12369","article-title":"Metformin usage in type 2 diabetes mellitus: Are safety guidelines adhered to?","volume":"44","author":"Huang","year":"2014","journal-title":"Internal Medicine Journal"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0010","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/15563650.2014.880174","article-title":"The enigma of metformin-associated lactic acidosis","volume":"52","author":"Juurlink","year":"2014","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2050-6511-14-22","article-title":"The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis","volume":"14","author":"Kajbaf","year":"2013","journal-title":"BMC pharmacology toxicology"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/pds.3689","article-title":"Mortality rate in so-called \"metformin-associated lactic acidosis\": A review of the data since the 1960s","volume":"23","author":"Kajbaf","year":"2014","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5694\/j.1326-5377.2008.tb01713.x","article-title":"Metformin and lactic acidosis in an Australian community setting: The Fremantle Diabetes Study","volume":"188","author":"Kamber","year":"2008","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0145","doi-asserted-by":"crossref","first-page":"e23200","DOI":"10.1371\/journal.pone.0023200","article-title":"Management of metformin-associated lactic acidosis by continuous renal replacement therapy","volume":"6","author":"Keller","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: An update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.jdiacomp.2015.06.001_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00003495-199958001-00013","article-title":"Lactic acidosis in metformin therapy","volume":"58","author":"Lalau","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002018-199920040-00006","article-title":"Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations","volume":"20","author":"Lalau","year":"1999","journal-title":"Drug Safety"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1463-1326.2001.00128.x","article-title":"Lactic acidosis in metformin therapy: Searching for a link with metformin in reports of 'metformin-associated lactic acidosis'","volume":"3","author":"Lalau","year":"2001","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1441-2772(23)00614-2","article-title":"Acid\u2013base balance: Part II. Pathophysiology","volume":"3","author":"McNamara","year":"2001","journal-title":"Critical Care and Resuscitation"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0105","series-title":"Therapeutic Goods Administration","author":"Medical Dictionary for Regulatory Activities - MedDRA","year":"2013"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","article-title":"Lactic acidosis in patients with diabetes treated with metformin","volume":"338","author":"Misbin","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00003246-199201000-00020","article-title":"Lactic acidosis in critical illness","volume":"20","author":"Mizock","year":"1992","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0195","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/00002030-200207050-00005","article-title":"Hyperlactataemia and lactic acidosis during antiretroviral therapy: Relevance, reproducibility and possible risk factors","volume":"16","author":"Moyle","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0150","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/ndt\/gfh337","article-title":"Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis","volume":"19","author":"Panzer","year":"2004","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0210","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/cc11663","article-title":"Metformin overdose causes platelet mitochondrial dysfunction in humans","volume":"16","author":"Protti","year":"2012","journal-title":"Critical Care"},{"issue":"17 Suppl. 1","key":"10.1016\/j.jdiacomp.2015.06.001_bb0125","first-page":"45","article-title":"Metformin-associated lactic acidosis requiring hospitalization. A national 10year survey and a systematic literature review","author":"Renda","year":"2013","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0175","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: A retrospective cohort study","volume":"37","author":"Richy","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5301\/jn.5000166","article-title":"Metformin in patients with chronic kidney disease: Strengths and weaknesses","volume":"26","author":"Rocha","year":"2013","journal-title":"Journal of Nephrology"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0085","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","author":"Salpeter","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0185","first-page":"U288-U","article-title":"An unusual case of lactic acidosis","volume":"38","author":"Sam","year":"2010","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.01.2010.2665","article-title":"Salbutamol: Beware of the paradox!","volume":"2010","author":"Saxena","year":"2010","journal-title":"BMJ Case reports"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabet.2013.02.006","article-title":"Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes","volume":"39","author":"Scheen","year":"2013","journal-title":"Diabetes & Metabolism"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1445-5994.2009.01959.x","article-title":"Acidosis in the hospital setting: is metformin a common precipitant?","volume":"40","author":"Scott","year":"2010","journal-title":"Internal Medicine Journal"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2796.2003.01271.x","article-title":"Metformin and lactic acidosis: Cause or coincidence? A review of case reports","volume":"255","author":"Stades","year":"2004","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0060","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.39255.669444.AE","article-title":"Metformin, heart failure, and lactic acidosis: Is metformin absolutely contraindicated?","volume":"335","author":"Tahrani","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2710.2010.01192.x","article-title":"Metformin associated lactic acidosis: Incidence and clinical correlation with metformin serum concentration measurements","volume":"36","author":"van Berlo-van de Laar","year":"2011","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/15563650.2013.860985","article-title":"Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy","volume":"52","author":"Vecchio","year":"2014","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF02440866","article-title":"Metformin-associated lactic acidosis in Sweden 1977\u20131991","volume":"44","author":"Wiholm","year":"1993","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jdiacomp.2015.06.001_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2004.01328.x","article-title":"The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: A systematic review","volume":"256","author":"Wulffele","year":"2004","journal-title":"Journal of Internal Medicine"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872715002263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872715002263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T13:33:22Z","timestamp":1717940002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872715002263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1056872715002263"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.06.001","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse event notifications implicating metformin with lactic acidosis in Australia","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}